Key Insights

Highlights

Treatment Research

2 treatments under study, led by Breast Milk Fortifier Supplements

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Unknown1
Active Not Recruiting1

Clinical Trials (2)

Research Network

Common Treatments

  • Breast Milk Fortifier Supplements1
  • Betaine Supplement1

Active Sponsors

  • Fundació Sant Joan de Déu1
  • Ankara City Hospital Bilkent1

Related Conditions

  • Premature1

Activity Timeline